Thrombosis Research

Aims & Scope

Thrombosis Research is an international journal with a goal of rapid dissemination of new information on thrombosis, hemostasis, and vascular biology to advance science and clinical care.

The journal publishes peer-reviewed original research, along with reviews, editorials, and opinions and critics.

Both basic and clinical studies are published.

Publication of research which will lead to novel approaches in diagnosis, therapy, prognosis and prevention of thrombotic and hemorrhagic diseases is given high priority.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.4
2024	3.70

SJR (SCImago Journal Rank)

Year	Value
2024	0.972

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	134

Journal Rank

Year	Value
2024	5062

Journal Citation Indicator

Year	Value
2024	2362

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Incidence of thrombotic complications in critically ill ICU patients with COVID-19

  Citation: 3560

  Authors: F.A., M.J.H.A., N.J.M., M.S., D.A.M.P.J., K.M., F.H.J., J., M.A.M., M.V., H.

• Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy

  Citation: 1649

  Authors: Corrado, Giacomo, Luca, Maurizio, Paola, Tim, Nils, Jan-Dirk, Clara, Alexia, Maria Teresa, Stefano

• Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis

  Citation: 1278

  Authors: F.A., M.J.H.A., N.J.M., M.S., D., K.M., F.H.J., J., M.A.M., M.V., H.

• The mechanism of action of aspirin

  Citation: 903

  Authors: J.R, R.M

• Growth and function of the normal human placenta

  Citation: 740

  Authors: Neil M., Claire T., Bill, Roger G.

• Coagulation and sepsis

  Citation: 629

  Authors: Marcel, Tom

• Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects

  Citation: 533

  Authors: Carlo, Giovanni, Elenora, Francesco, Gioacchino, Antonio, Maria A., Bernhard A.

• The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management

  Citation: 527

  Authors: Mouhamed Yazan, Akiva, Sargam, Yasmin, Lalitha

• Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium

  Citation: 520

  Authors: S., A.G., E.A., J.R.

• Haemostatic changes in pregnancy

  Citation: 484

  Authors: Benjamin

---